<DOC>
	<DOCNO>NCT00634985</DOCNO>
	<brief_summary>To assess safety efficacy eletriptan treatment migraine subject adequately treat non-steroidal antiinflammatory drug ( NSAIDs )</brief_summary>
	<brief_title>Safety Efficacy Eletriptan Treatment Migraine Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Eletriptan</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Met International Headache Society diagnostic criterion migraine without aura Expected suffer one six acute migraine attack per month base past history Experienced migraine least one year prior enter study , historically respond NSAIDs Frequent migraine frequent concomitant nonmigrainous headache ( average &gt; 6 attack per month ) Atypical migraine consistently fail respond adequate medical therapy Migraine prolong aura , familial hemiplegic migraine , basilar migraine , migrainous infarction , migraine aura without headache , migraine acuteonset aura</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>